32 related articles for article (PubMed ID: 20712564)
21. Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR).
Kumari A; Singh RK
Bioorg Chem; 2020 Mar; 96():103578. PubMed ID: 31978684
[TBL] [Abstract][Full Text] [Related]
22. Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies.
Tzara A; Xanthopoulos D; Kourounakis AP
ChemMedChem; 2020 Mar; 15(5):392-403. PubMed ID: 32017384
[TBL] [Abstract][Full Text] [Related]
23. Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules.
Kourounakis AP; Xanthopoulos D; Tzara A
Med Res Rev; 2020 Mar; 40(2):709-752. PubMed ID: 31512284
[TBL] [Abstract][Full Text] [Related]
24. Medicinal chemistry of 2,2,4-substituted morpholines.
Rekka EA; Kourounakis PN
Curr Med Chem; 2010; 17(29):3422-30. PubMed ID: 20712564
[TBL] [Abstract][Full Text] [Related]
25. Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis.
Matralis AN; Bavavea EI; Incerpi S; Pedersen JZ; Kourounakis AP
Curr Med Chem; 2017; 24(12):1214-1227. PubMed ID: 27528055
[TBL] [Abstract][Full Text] [Related]
26. Development of Fibrates as Important Scaffolds in Medicinal Chemistry.
Giampietro L; Ammazzalorso A; Amoroso R; De Filippis B
ChemMedChem; 2019 Jun; 14(11):1051-1066. PubMed ID: 30957432
[TBL] [Abstract][Full Text] [Related]
27. Squalene synthase inhibitors: An update on the search for new antihyperlipidemic and antiatherosclerotic agents.
Kourounakis AP; Katselou MG; Matralis AN; Ladopoulou EM; Bavavea E
Curr Med Chem; 2011; 18(29):4418-39. PubMed ID: 21864285
[TBL] [Abstract][Full Text] [Related]
28. EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitors.
Tavridou A; Manolopoulos VG
Curr Pharm Des; 2009; 15(27):3167-78. PubMed ID: 19754389
[TBL] [Abstract][Full Text] [Related]
29. Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.
Hall IH; Chen SY; Rajendran KG; Sood A; Spielvogel BF; Shih J
Environ Health Perspect; 1994 Nov; 102 Suppl 7(Suppl 7):21-30. PubMed ID: 7889876
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
